Atlas Trials

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer

Clinical trial NCT05227378 · UNKNOWN

Trial details

NCT number
NCT05227378
Sponsor
Shen Lin
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2022-03-01
Primary completion
2025-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.